Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ESALF
ESALF News & Events
-
Add to Watchlist
Trade ESALF
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
ESALF News
Merck and Eisai's Combination Therapy Achieves Major Milestone in Advanced Kidney Cancer Study
Oct 28 2025
SeekingAlpha
Biogen Secures Approval for At-Home Version of Alzheimer's Medication Leqembi
Aug 29 2025
SeekingAlpha
FDA advises enhanced oversight for Alzheimer's patients using Leqembi
Aug 29 2025
SeekingAlpha
Biogen/ Eisai win EU approval for Alzheimer’s therapy
Apr 15 2025
SeekingAlpha
J.P. Morgan Reaffirms Their Hold Rating on Eisai Co (ESALF)
Mar 08 2025
Business Insider
Eisai projects 42.5B yen global revenue for LEQEMBI in FY2024 amid pathway expansion
Feb 08 2025
SeekingAlpha
Eisai GAAP EPS of ¥160.14, revenue of ¥601.16B; reaffirms FY outlook
Feb 07 2025
SeekingAlpha
Biogen, Eisai Alzheimer’s drug review delayed in EU
Jan 31 2025
SeekingAlpha
Show More News
ESALF Events
No data
ESALF Monitor News
No data
ESALF Earnings Analysis
No Data
People Also Watch
